REKOVELLE 72 micrograms/2.16 mL solution for injection in a pre-filled pen

DRUG6 trials

Sponsors

Ferring Pharmaceuticals A/S, Santiago Dexeus Font Fundacio Privada, Universitair Ziekenhuis Brussel, Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA

Conditions

Idiopathic male infertility (including oligoasthenozoospermia).InfertilityInfertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycleVolutary women who wish to donate their oocytesWomen with infertility and low ovarian reserve.infertility

Phase 2

A randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of FE 999049 for treatment of men with idiopathic infertility

CompletedCTIS2023-508430-34-00

Ferring Pharmaceuticals A/SIdiopathic male infertility (including oligoasthenozoospermia).

Start: 2023-01-12End: 2024-10-23Target: 197Updated: 2024-10-16

Phase 3

A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the ovarian response after controlled ovarian stimulation with mixed protocols of follitropin delta (REKOVELLE) and highly purified human menopausal gonadotropin (MENOPUR) in women undergoing an assisted reproductive technology programme

Not yet recruitingCTIS2022-500308-23-00

Ferring Pharmaceuticals A/SInfertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle

Target: 115Updated: 2022-11-09

Phase 4

The impact of ovarian stimulation intensity on embryo euploidy in advanced age women. A randomized controlled trial

RecruitingCTIS2023-507028-22-00

Santiago Dexeus Font Fundacio PrivadaInfertility

Start: 2023-12-12Target: 110Updated: 2024-07-04

Luteal phase ovarian stimulation with Follitropin delta and dydrogesterone: a randomized cross over pilot trial

RecruitingCTIS2024-513998-48-00

Universitair Ziekenhuis BrusselVolutary women who wish to donate their oocytes

Start: 2023-02-02Target: 50Updated: 2024-07-31

The impact of ovarian stimulation with hMG on embryo quality in advanced age women. A randomized controlled trial

Not yet recruitingCTIS2025-524761-25-00

Santiago Dexeus Font Fundacio Privadainfertility

Target: 240Updated: 2026-06-23

Phase IV randomized, single-blind clinical trial with three parallel arms to compare ovulation triggering strategies in IVF cycles with fresh embryo transfer.

RecruitingCTIS2026-526292-37-01

Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVAWomen with infertility and low ovarian reserve.

Target: 126Updated: 2026-07-13